We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
-16.25%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
-$758M
Cap. Flow
-$358M
Cap. Flow %
-22.01%
Top 10 Hldgs %
47.54%
Holding
408
New
22
Increased
69
Reduced
110
Closed
53

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$21.2M
2
LLY icon
Eli Lilly
LLY
+$19.2M
3
MCD icon
McDonald's
MCD
+$9.1M
4
DHI icon
D.R. Horton
DHI
+$8.44M
5
LIN icon
Linde
LIN
+$8.43M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$53.8M
2
UPS icon
United Parcel Service
UPS
+$49.1M
3
PANW icon
Palo Alto Networks
PANW
+$48.1M
4
GS icon
Goldman Sachs
GS
+$45.4M
5
CVX icon
Chevron
CVX
+$41.4M

Sector Composition

Rank Sector Weight
1 Technology 23.86%
2 Industrials 17.87%
3 Healthcare 12.42%
4 Consumer Discretionary 9.18%
5 Consumer Staples 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MUFG icon
201
Mitsubishi UFJ Financial
MUFG
$254B
$374K 0.02%
70,000
– –
WCN
202
Waste Connections
WCN
$42.3B
$372K 0.02%
3,000
– –
LHX icon
203
L3Harris
LHX
$51.7B
$363K 0.02%
1,500
– –
SCI icon
204
Service Corp International
SCI
$11.7B
$363K 0.02%
5,248
– –
ADSK icon
205
Autodesk
ADSK
$49.6B
$361K 0.02%
2,100
-308
-13% -$59.2K
CSCO icon
206
Cisco
CSCO
$457B
$361K 0.02%
8,475
-400
-5% -$19.1K
A icon
207
Agilent Technologies
A
$39.5B
$356K 0.02%
3,000
– –
CRSP icon
208
CRISPR Therapeutics
CRSP
$4.88B
$356K 0.02%
5,850
-10
-0.2% -$588
REGN icon
209
Regeneron Pharmaceuticals
REGN
$78.2B
$355K 0.02%
600
– –
HEI icon
210
HEICO Corp
HEI
$50.4B
$354K 0.02%
2,700
-300
-10% -$42.3K
CRWD icon
211
CrowdStrike
CRWD
$206B
$350K 0.02%
8,300
-1,900
-19% -$86K
NFLX icon
212
Netflix
NFLX
$305B
$349K 0.02%
19,940
-862,200
-98% -$19.1M
FSLR icon
213
First Solar
FSLR
$25B
$348K 0.02%
5,110
– –
SSL icon
214
Sasol
SSL
$7.21B
$346K 0.02%
15,000
– –
STLA icon
215
Stellantis
STLA
$21.3B
$346K 0.02%
28,000
– –
AVGO icon
216
Broadcom
AVGO
$1.87T
$345K 0.02%
7,100
– –
CF icon
217
CF Industries
CF
$18.2B
$343K 0.02%
4,000
-1,000
-20% -$97.2K
SKM icon
218
SK Telecom
SKM
$12.4B
$339K 0.02%
15,184
– –
AVUS icon
219
Avantis US Equity ETF
AVUS
$14.2B
$338K 0.02%
+5,190
New +$368K
VMI icon
220
Valmont Industries
VMI
$9.43B
$337K 0.02%
1,500
-500
-25% -$122K
AEP icon
221
American Electric Power
AEP
$69.9B
$336K 0.02%
3,500
– –
PXD
222
DELISTED
Pioneer Natural Resource Co.
PXD
$335K 0.02%
1,500
-500
-25% -$127K
PLUG icon
223
Plug Power
PLUG
$2.9B
$331K 0.02%
20,000
– –
STLD icon
224
Steel Dynamics
STLD
$37B
$331K 0.02%
5,000
-2,000
-29% -$160K
CW icon
225
Curtiss-Wright
CW
$27.6B
$330K 0.02%
2,500
– –
7 8
9
10 11

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q2 2022 Portfolio in Review

As of Q2 2022, R.H. Bluestein & Co held 408 positions worth $1.63B, down 32% from $2.39B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

R.H. Bluestein & Co withdrew a net $358M in Q2 2022, closing 53 positions and reducing 110 holdings. Its most notable exit was Goldman Sachs, an estimated $45.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, R.H. Bluestein & Co opened a new position in Eli Lilly worth $20.7M.

  • R.H. Bluestein & Co's largest Q2 2022 buy was Eli Lilly: 63,984 shares worth $20.7M.
  • R.H. Bluestein & Co added most to Analog Devices in Q2 2022, an estimated $21.2M increase.
  • R.H. Bluestein & Co's biggest Q2 2022 reduction was Home Depot, cutting an estimated $53.8M.
  • R.H. Bluestein & Co fully exited Goldman Sachs in Q2 2022, selling an estimated $45.4M.
  • R.H. Bluestein & Co's ten largest holdings make up 48% of its $1.63B portfolio in Q2 2022.
  • R.H. Bluestein & Co opened 22 new positions and closed 53 in Q2 2022.
  • R.H. Bluestein & Co's portfolio value fell 32% quarter-over-quarter to $1.63B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2022, filed 11 Aug 2022.